Search
for
Sort by
Research 451–480 of 1000+
- Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Benign Prostatic Hyperplasia Pharmacotherapy and Incident Ocular Surface Disease: Comparative Risk of Alpha-Blockers vs 5-Alpha Reductase Inhibitors
- Adverse effects of finasteride in men treated for benign prostatic hyperplasia and androgenetic alopecia - a literature review
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Asociación entre disfunción eréctil y funcionalidad del subsistema conyugal en pacientes con hiperplasia prostática benigna
- The prostaglandin synthases, COX-2 and L-PGDS, mediate prostate hyperplasia induced by low-dose bisphenol A
- Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus)
- Effects of 5-alpha reductase inhibitors
- Pharmacophore and Atom Based 3D QSAR Studies on the Novel 5-Alpha-Reductase Inhibitors
- Novel inhibitors of 5α-reductase
- 5α-Metabolism in Finasteride-Treated Subjects and Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency
- Targeting a fibrotic bottleneck may provide an opening in the treatment of LUTS
- Post-finasteride syndrome – does it really exist?
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Edible seeds from Cucurbitaceae family as potential functional foods: Immense promises, few concerns
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- Finasteride, A Steroid 5α-Reductase Inhibitor, Does Not Affect the Oxidative Metabolism of Antipyrine
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Complications of cataract surgery in Wistar rats undergoing treatment with tamsulosin
- Isolation and Structural Characterization of Finasteride Degradation Products by Preparative HPLC, HRMS, and NMR
- METHOD DEVELOPMENT AND VALIDATION OF UV-SPECTROPHOTOMETRIC ESTIMATION OF FINASTERIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM
- “Acute Pancreatitis Following Finasteride Toxicity: A Rare Case Report"
- The pathophysiology of delayed ejaculation
- Effects of <i>Lespedeza Cuneata aqueous extract</i> on testosterone-induced prostatic hyperplasia